Table 2 CV risk algorithms of the patients with axSpA.
Entire axSpA population (n = 295) | axSpA without CV event (n = 272) | axSpA with CV event (n = 23) | P | |
|---|---|---|---|---|
CUORE | 2.2 (0.9–6) | 2 (0.9–5.4) | 4.95 (1.7–12.7) | 0.01 |
CUORE*1.5 | 3.3 (1.35–9) | 3 (1.35–8.1) | 7.425 (2.55–19.05) | 0.01 |
FRS | 6.8 (3.8–15.6) | 6.5 (3.5–15) | 13.35 (6.7–23.8) | 0.02 |
FRS*1.5 | 10.2 (5.7–23.4) | 9.75 (5.25–22.5) | 20.025 (10.05–35.7) | 0.02 |
QRISK2 | 4.1 (1.7–12.3) | 3.65 (1.5–10.7) | 12.5 (5.8–22.3) | 0.002 |
QRISK2-RA | 5.25 (2.25–15.65) | 4.75 (2–13.7) | 16.16 (7.6–28) | 0.002 |
QRISK3 | 3.7 (1.5–10.9) | 3.3 (1.4–10.1) | 12.25 (5–20) | 0.002 |
QRISK3-RA | 4.6 (1.9–13.25) | 4.1 (1.7–12.3) | 14.95 (6.1–24) | 0.002 |
RRS | 3 (2–7) | 2.5 (2–7) | 6.5 (4–12) | 0.006 |
RRS*1.5 | 4.5 (3–10.5) | 3.75 (3–10.5) | 9.75 (6–18) | 0.006 |
ASSIGN | 6 (4–13) | 6 (3–13) | 13 (6–28) | 0.006 |
ASSIGN-RA | 8 (4–16) | 7 (4–16) | 16.5 (7–35) | 0.004 |
HeartScore | 1 (1–2) | 1 (1–2) | 1 (1–4) | 0.047 |
HeartScore*1.5 | 1.5 (1.5–3) | 1.5 (1.5–3) | 1.5 (1.5–6) | 0.047 |
